AstraZeneca, a British-Swedish multinational pharmaceutical and biotechnology company, has revealed its plans to construct sustainable offices at Dubai Science Park, a member of TECOM Group.
Set to open in Q3 2023, the move is part of the company’s global green agenda and in line with “We the UAE 2031” vision and the Year of Sustainability.
The new office design, construction, and materials will meet platinum standards in Leadership in Energy and Environmental Design (LEED) set out by the US Green Building Council (USGBC). The Green Building Classification System is one of the most widely used worldwide and a marker of healthy, efficient, and carbon-saving buildings.
“Health and sustainability go hand-in-hand. We cannot improve our collective well-being without putting the planet’s health first. Such foresight is what puts AstraZeneca among the world’s leading biopharmaceutical firms. They champion sustainability in healthcare, and their new offices in Dubai Science Park will add another benchmark for the industry. By joining our community of global and regional businesses across the health, energy and environment sectors, AstraZeneca can amplify their green efforts while promoting excellence in healthcare and research.”
Mr. Sameh El Fangary, GCC and Pakistan Cluster President of AstraZeneca, commented that “Everyone involved in the delivery of healthcare has a role to play in addressing the global threat of climate change. Our new green offices will help us expand our local footprint in the UAE and demonstrate our support for the government’s ambition to drive and accelerate sustainable development in healthcare. We are taking bold action, guided by our ‘Ambition Zero Carbon’ strategy, to reduce our environmental footprint and inspire continued collaboration globally and in the region.”
President His Highness Sheikh Mohamed bin Zayed Al Nahyan designated 2023 as the “Year of Sustainability” leading up to the highly anticipated COP28 conference, to be held in Dubai later this year. The new offices represent AstraZeneca’s commitment to the UAE Sustainability Goals and its global “Ambition Zero Carbon” strategy, which aims to eliminate carbon emissions from its global operations by 2025.
AstraZeneca is a champion of the Sustainable Markets Initiative (SMI) Health Systems Task Force, a public-private partnership committed to accelerating the delivery of net zero healthcare systems. The company recently held its first multilateral engagement on health and climate at COP27, bringing together members of the SMI, the World Health Organization (WHO) and the Commonwealth Secretariat to announce new joint action to accelerate net zero healthcare in three areas: supply chains, patient care pathways, and clinical trials.